Latest filings (excl ownership)
REVOKED
Registration or securities revoked
17 Jul 23
8-K
Calmare Therapeutics Awarded $2.5 Million, Five-year
9 Jun 20
8-K
Other Events
5 Nov 19
8-K
Departure of Directors or Certain Officers
19 Jul 19
8-K
Departure of Directors or Certain Officers
12 Jun 19
8-K
Other Events
10 Jun 19
8-K
Other Events
3 Jun 19
8-K
Calmare Therapeutics Receives Two Favorable Rulings
25 Mar 19
8-K
Other Events
18 Mar 19
8-K/A
Submission of Matters to a Vote of Security Holders
2 Jul 18
DEFA14A
Additional proxy soliciting materials
2 Jul 18
8-K
Submission of Matters to a Vote of Security Holders
15 Jun 18
DEFA14A
Additional proxy soliciting materials
15 Jun 18
8-K
Entry into a Material Definitive Agreement
4 May 18
DEFA14A
Additional proxy soliciting materials
4 May 18
8-K
Other Events
20 Feb 18
DEFA14A
Additional proxy soliciting materials
20 Feb 18
DFAN14A
Additional proxy materials by non-management
20 Feb 18
8-K
Other Events
16 Feb 18
8-K
Unregistered Sales of Equity Securities
16 Feb 18
DEFA14A
Additional proxy soliciting materials
16 Feb 18
DFAN14A
Additional proxy materials by non-management
16 Feb 18
DFAN14A
Additional proxy materials by non-management
9 Feb 18
DEFR14A
Revised proxy
16 Jan 18
PRER14A
Preliminary revised proxy
12 Jan 18
8-K
Other Events
8 Jan 18
DEFA14A
Additional proxy soliciting materials
8 Jan 18
PRE 14A
Preliminary proxy
2 Jan 18
8-K/A
Changes in Registrant's Certifying Accountant
21 Dec 17
8-K
Departure of Directors or Certain Officers
19 Dec 17
8-K
Changes in Registrant's Certifying Accountant
18 Dec 17
DFAN14A
Additional proxy materials by non-management
8 Dec 17
DEFC14A
Proxy in contested solicitation
5 Dec 17
PREC14A
Preliminary proxy with contested solicitation
4 Dec 17
PREN14A
Preliminary proxy statement filed by non-management
22 Nov 17
NT 10-Q
Notice of late quarterly filing
15 Nov 17
8-K
Changes in Registrant's Certifying Accountant
14 Sep 17
NT 10-Q
Notice of late quarterly filing
16 Aug 17
10-K
2016 FY
Annual report
21 Jul 17
NT 10-K
Notice of late annual filing
31 Mar 17
Latest ownership filings
SC 13G/A
CALMARE THERAPEUTICS Inc
11 Feb 20
SC 13G/A
CALMARE THERAPEUTICS Inc
14 Feb 19
4
Thomas Philip Richtarich
6 Mar 18
4
Conrad F Mir
6 Mar 18
4
Peter F Brennan
6 Mar 18
SC 13G/A
CALMARE THERAPEUTICS Inc
14 Feb 18
SC 13G
CALMARE THERAPEUTICS Inc
13 Feb 18
SC 13D/A
CALMARE THERAPEUTICS Inc
21 Sep 17
SC 13D
CALMARE THERAPEUTICS Inc
30 Jun 17
SC 13G
CALMARE THERAPEUTICS Inc
14 Feb 17
SC 13G
CALMARE THERAPEUTICS Inc
1 Feb 16
4
RUSTIN R HOWARD
3 Jun 15
4
STAN YARBRO
1 Jun 15
4
ROBERT G MOUSSA
20 May 15
4
Peter F Brennan
19 May 15
SC 13G/A
CALMARE THERAPEUTICS Inc
16 Mar 15
SC 13G
CALMARE THERAPEUTICS Inc
17 Feb 15
SC 13G/A
Beneficial ownership report (amended)
6 Feb 15
SC 13G/A
Beneficial ownership report (amended)
4 Feb 14
SC 13G/A
Competitive Technologies Inc
23 Jan 14
SC 13G
Competitive Technologies Inc
27 Sep 13
SC 13G
Competitive Technologies Inc
12 Aug 13
SC 13D/A
Brennan Peter F
17 Dec 10
SC 13D
Brennan Peter F
21 Sep 10